CRIP1 and ovarian cancer: The results show that the upregulation of CRIP1 can promote ovarian cancer invasion, metastasis, and EMT by activating the Wnt signaling pathway, suggesting that CRIP1 could be viewed as a valuable new biomarker for ovarian cancer.